The beneficiaries

- Patients will have access to state of the art diagnostic and therapeutic facilities
- Opportunities for improved quality and quantity of patient survival, together with a better understanding of the impact on the family unit
- Rewards for collaborating Trusts seeking external funding
- Scientists and clinicians who have made it their life’s work to tackle this disease

